ISRCTN49141161进行中（未招募）2 期
oDe-pOsitive penile cancer and FDG-PET/CT – does PET modify treatment? (DO PET)
Skåne University Hospital0 个研究点目标入组 100 人开始时间: 2023年6月29日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Male
入选标准
- •Node-positive penile cancer (cN+ or cN3 after sentinel node biopsy)
排除标准
- •Age below 18 years
研究者
相似试验
尚未招募
不适用
Quantitative FDG-PET/CT of primary bladder cancer1003836410004994Bladder cancerbladder carcinomaNL-OMON33365Antoni van Leeuwenhoek Ziekenhuis10
进行中（未招募）
不适用
PET-CT DIAGNOSIS OF CARCINOMA PROSTATICO WITH ALTERNATIVE TO FLUORODESOSSIGLUCOSIO Radio: 18F-COLINA - NDProstate cancerEUCTR2008-004236-20-ITAZIENDA OSPEDALIERA ARCISPEDALE S. MARIA NUOVA
尚未招募
Unknown
To prove diagnostic accuracy of PET/CT in all cancer penis patients having groin involvement clinically. If we can prove diagnostic accuracy of the pelvic lymph node involvement, then we can avoid pelvic surgery which will be reduce complications associated with surgery.CTRI/2022/03/041401IRB committee CMC Vellore
招募中
不适用
Evaluation of new PET tracer, [F-18]Florastamin for diagnosing prostate cancer: Phase I clinical trialKCT0004817FutureChem10
已完成
不适用
18F-DCPYL-Positron Emission Tomography (PET) for diagnosis of primary prostate cancer in men with positive multiparametric magnetic resonance imaging (mpMRI) and negative biopsyprimary prostate cancer in men with positive mpMRI and negative biopsyCancer - ProstateACTRN12621001674820St Vincent's Hospital Melbourne29